Healthcare / Medical Care FacilitiesAthens
$1.80
+0.00 (+0.28%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $3.8M · quality 37.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
24/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$156M
P/E
N/A
•EV/EBITDA
11.1x
↓ROE
-4.5%
↓Gross Margin
20.4%
↓Debt/Equity
1.76
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+5.7%
FCF CAGR
—
FCF margin
-4.3%
FCF / Net income
2.53x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $275.8M · net income $-4.7M · FCF $-11.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $275.8M | $275.8M | $269.8M | $258.4M | $233.4M |
| Net Income | $-4.7M | $-4.7M | $1.8M | $8.1M | $6.8M |
| EBITDA | $27.8M | $27.8M | $32.0M | $38.0M | $32.1M |
| EPS | -0.05 | -0.05 | 0.02 | 0.09 | 0.08 |
| Gross Margin | 20.4% | 20.4% | 22.5% | 25.8% | 24.3% |
| Operating Margin | 1.4% | 1.4% | 4.4% | 8.0% | 7.1% |
| Net Margin | -1.7% | -1.7% | 0.7% | 3.1% | 2.9% |
| Balance Sheet | |||||
| Debt/Equity | 1.76 | 1.76 | 1.36 | 1.46 | 1.40 |
| Current Ratio | 0.81 | 0.81 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-11.8M | $-11.8M | $19.8M | $3.8M | $-15.8M |
| Returns | |||||
| ROE | -4.5% | -4.5% | 1.6% | 7.4% | 6.6% |
| Valuation | |||||
| P/E | — | — | 81.71 | 19.85 | 21.55 |
| EV/EBITDA | 11.05 | 11.05 | 8.60 | 7.82 | 8.55 |
| P/B | 1.50 | 1.50 | 1.34 | 1.48 | 1.43 |
| Growth & Yield | |||||
| Revenue Growth | 2.2% | 2.2% | 4.4% | 10.7% | — |
| EPS Growth | -362.4% | -362.4% | -78.0% | 18.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+3.4%
Start / end P/E
n/dx → n/dx
EPS bridge
0.02 → -0.05
Residual
+3.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.